Posted On: 11/09/2016 4:21:13 PM
Post# of 9144
You would have to assume the product would first be used where Faro works. Would you agree to this statement?
They could monitor quality and more importantly work out any kinks. Would you agree?
It would also serve as a proof source of the product in action.
There is still pending test data from U.S. federal agency and large medical device company. I see this as a catalyst in itself.
It's refreshing to hear the word investors. If they turn out to be big time investors, this would also be a catalyst.
Looks like their will be plenty of news coming in the next few months and I expect good price momemtum from here.
I rate this as a strong buy. Its only 17 cents.
They could monitor quality and more importantly work out any kinks. Would you agree?
It would also serve as a proof source of the product in action.
There is still pending test data from U.S. federal agency and large medical device company. I see this as a catalyst in itself.
It's refreshing to hear the word investors. If they turn out to be big time investors, this would also be a catalyst.
Looks like their will be plenty of news coming in the next few months and I expect good price momemtum from here.
I rate this as a strong buy. Its only 17 cents.
(3)
(0)
